Celgene Hema/Onco Pricing, Reimbursement & HEOR Lead, Senior Manager in Milan, Italy

Description

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, ​quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.

Role and Responsibilities:

  • Prepare the national P&R dossier by coordinating other relevant Functions and develop analytical approach/negotiation strategy.

  • Ensure support to Market Access organisation (AVM e RVM) in the regional/local formulary listing process and afterward, where required, by preparing tools (ie Regional Dossier, BIM, HE slide deck) and by promoting integrated activities in the field.

  • Develop tactical plans to support products’ value by exploring market opportunities and by promoting the execution of health economics studies, RWE, economic models and any other appropriate initiative to sustain products’ value along their lifecycle.

  • Assess the market access landscape, prepare the market access SWOT analysis and propose solutions to fill the evidence gaps for early compounds in order to contribute in influencing and complementing the global clinical development plan for reimbursement purposes, in cooperation with Medical and with EMEA.

  • Represent the Pricing, Reimbursement and HEOR function in the Disease Team/Task Force.

  • Contribute to EMEA Market Access working groups/task forces and EMEA projects, as requested.

  • Constantly monitor scientific and health economics articles, relevent to assigned disease areas.

  • Support the Pricing, Reimbursement and HEOR Director in developing training toolkit for internal stakeholders.

Skills and Knowledge Requirements:

  • Solid scientific/economics background

  • Experience in pharmaceutical industry

  • Experience in P&R dossier preparation and Market Access

  • Ability to interpret and critique clinical study protocols

  • HE analysis and business intelligence background

  • Excel Skills at an intermediate level is a plus

  • Proficiency in English required

  • Flexibility to deal with ambiguity and change

COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE